This activity includes patient counseling videos.
This activity is part 2 of a 3-part series.
Program Description
The use of direct oral anticoagulant (DOAC) agents is guided by recommendations based on new and evolving evidence derived from emerging trial data. However, the management of DOACs must still be tailored to patient needs based on goals of anticoagulation therapy and individualized thrombotic risk and risk for bleeding. This webinar will examine the indications and dosing of each available DOAC as well as considerations for their use in special situations. Additionally, patient counseling video vignettes will highlight the role of the pharmacist in counseling a patient taking a DOAC on important dosing and safety considerations.
Target audience: Health-system pharmacists, retail pharmacists
Type of activity: Application
Release date: July 12, 2023
Expiration date: July 12, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine the 4 available direct oral anticoagulant (DOAC) agents
- Identify indications specific to each DOAC, as well as relevant warnings, precautions, and contraindications
- Analyze pivotal clinical trial data that support the indications and special circumstances for each agent
Sarah Hanigan Lewis, PharmD
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Clinical Pharmacy Specialist in Cardiology and Anticoagulation
Department of Pharmacy Services
Michigan Medicine
Ann Arbor, Michigan
Brooke Fidler, PharmD, CHSE
Medical Writer for Patient Counseling Videos
Associate Professor of Pharmacy Practice
Director of Co-Curricular Affairs and Patient Simulation
LIU Pharmacy (Arnold and Marie Schwartz College of Pharmacy and Health Sciences)
Brooklyn, New York
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-302-H01-P. The activity is available for CE credit through July 12, 2024.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Sarah Hanigan Lewis, PharmD
Medical Writer
Brooke Fidler, PharmD, CHSE
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms